Share |

FDA: Proton Pump Inhibitors Could Increase Fracture Risk

Posted on 04. Jun, 2010 by in Clinical Notes

PPIs linked to wrist, hip, spine fractures.

Putting residents on proton pump inhibitors long-term or at high doses may be fraught with fracture risk.

Recently, the Food and Drug Administration  (FDA) has ordered a revision to the prescription and over-the-counter...

Click here to login and get access to this article if you already receive the Long Term Care Wire
If you've already signed in and are still seeing this screen, click here to refresh the page.
Long Term Care News Wire
Free registration required for full access to articles.
You will also receive
  • Archive of MDS pointers, searchable by keyword or quality measure.
  • Staff training materials that help your SNF ace its surveys.
  • Training and implementation tools for MDS 3.0.
Join now
You must have javascript enabled to use this form
Bookmark and Share

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,